Gotowa bibliografia na temat „Surveillance immune”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Surveillance immune”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Surveillance immune"
Shastri, Nilabh, Chansu Park i Jian Guan. "Immune surveillance of immune surveillance". Molecular Immunology 150 (październik 2022): 2. http://dx.doi.org/10.1016/j.molimm.2022.05.018.
Pełny tekst źródłaSwann, Jeremy B., i Mark J. Smyth. "Immune surveillance of tumors". Journal of Clinical Investigation 117, nr 5 (1.05.2007): 1137–46. http://dx.doi.org/10.1172/jci31405.
Pełny tekst źródłaGrossman, Zvi, i Ronald B. Herberman. "‘Immune surveillance’ without immunogenicity". Immunology Today 7, nr 5 (maj 1986): 128–31. http://dx.doi.org/10.1016/0167-5699(86)90075-7.
Pełny tekst źródłaPrehn, Richmond T., i Liisa M. Prehn. "The flip side of immune surveillance: immune dependency". Immunological Reviews 222, nr 1 (kwiecień 2008): 341–56. http://dx.doi.org/10.1111/j.1600-065x.2008.00609.x.
Pełny tekst źródłaKim, Ryungsa, Manabu Emi i Kazuaki Tanabe. "Cancer immunoediting from immune surveillance to immune escape". Immunology 121, nr 1 (maj 2007): 1–14. http://dx.doi.org/10.1111/j.1365-2567.2007.02587.x.
Pełny tekst źródłaSchaller, Julien, i Judith Agudo. "Metastatic Colonization: Escaping Immune Surveillance". Cancers 12, nr 11 (16.11.2020): 3385. http://dx.doi.org/10.3390/cancers12113385.
Pełny tekst źródłaLowe, Scott. "Immune Surveillance of Senescent Cells". Innovation in Aging 5, Supplement_1 (1.12.2021): 246. http://dx.doi.org/10.1093/geroni/igab046.952.
Pełny tekst źródłaAhmad, Aamir. "Tumor microenvironment and immune surveillance". Microenvironment and Microecology Research 4, nr 1 (2022): 6. http://dx.doi.org/10.53388/mmr2022006.
Pełny tekst źródłaOh, Julia, i Derya Unutmaz. "Immune cells for microbiota surveillance". Science 366, nr 6464 (24.10.2019): 419–20. http://dx.doi.org/10.1126/science.aaz4014.
Pełny tekst źródłaZanetti, M., i N. R. Mahadevan. "Immune Surveillance from Chromosomal Chaos?" Science 337, nr 6102 (27.09.2012): 1616–17. http://dx.doi.org/10.1126/science.1228464.
Pełny tekst źródłaRozprawy doktorskie na temat "Surveillance immune"
Rosenthal, Rachel Suzanne. "Immune editing and surveillance in cancer evolution". Thesis, University College London (University of London), 2018. http://discovery.ucl.ac.uk/10047362/.
Pełny tekst źródłaSCHEIDECKER, CATHERINE. "Cellule nk : surveillance immune et resistance naturelle". Strasbourg 1, 1987. http://www.theses.fr/1987STR10724.
Pełny tekst źródłaMarri, Eswari. "Immune surveillance of activated immune and tumour cells by surfactant protein D". Thesis, Brunel University, 2015. http://bura.brunel.ac.uk/handle/2438/13847.
Pełny tekst źródłaKaur, Anuvinder. "Innate immune surveillance in ovarian and pancreatic cancer". Thesis, Brunel University, 2017. http://bura.brunel.ac.uk/handle/2438/15847.
Pełny tekst źródłaCheung, Ann F. "Investigating immune surveillance, tolerance, and therapy in cancer". Thesis, Massachusetts Institute of Technology, 2009. http://hdl.handle.net/1721.1/46809.
Pełny tekst źródłaThis electronic version was submitted by the student author. The certified thesis is available in the Institute Archives and Special Collections.
Vita.
Includes bibliographical references.
Maximizing the potential of cancer immunotherapy requires model systems that closely recapitulate human disease to study T cell responses to tumor antigens and to test immune therapeutic strategies. Current model systems largely relied on chemically-induced and spontaneous tumors in immunodeficient mice or on transplanted tumors. Such systems are limited because they fail to reproduce the complex interactions that exist among an emerging tumor, its microenvironment and the multiple elements of an intact immune system. We created a new system that is compatible with Cre-loxP-regulatable mouse cancer models in which the defined antigen SIY is specifically over-expressed in tumors, mimicking clinically-relevant tumor-associated antigens. To demonstrate the utility of this system, we characterized SIYreactive T cells in the context of lung adenocarcinoma, revealing multiple levels of antigenspecific T cell tolerance that serve to limit an effective anti-tumor response. Thymic deletion reduced the number of SIY-reactive T cells present in the animals. When potentially self-reactive T cells in the periphery were activated, they were efficiently eliminated. Inhibition of apoptosis resulted in more persistent self-reactive T cells, but these cells became anergic to antigen stimulation. Finally, in the presence of tumors over- expressing SIY, SIY-specific T cells required a higher level of costimulation to achieve functional activation.
(cont.) Adoptive cell transfer (ACT) therapy for cancer has demonstrated tremendous efficacy in clinical trials, particularly for the treatment of metastatic melanoma. There is great potential in broadening the application of ACT to treat other cancer types, but the threat of severe autoimmunity may limit its use. Studies in other model systems have demonstrated successful induction of anti-tumor immunity against self-antigens without detrimental autoimmunity. This is possibly due to the preferential recognition of tumor over normal somatic tissue by activated T cells. In our system, SIY provides a means to achieve this bias because of its over-expression in tumors. Thus, we applied adoptive T cell transfer therapy combined with lymphodepleting preconditioning to treat autochthonous lung tumors over-expressing SIY self-antigen. With this treatment, we overcame peripheral tolerance, successfully inducing large number of functional anti-tumor T cells. These T cells are able to influence lung tumors over-expressing self-antigen. Importantly, despite large numbers of potentially self-reactive T cells, we did not observed overt autoimmunity. Immune tolerance thwarts efforts to utilize immune therapy against cancer. We have discerned many mechanisms by which tolerance to cancer in potential achieved. Both Foxp3+ T regulatory cell and myeloid-derived suppressor cell populations are expanded in the presence of cancer in our mouse models.
(cont.) In addition, we identified LAG-3 as a potential factor that serves to limit anti-tumor T cell activity in the context of adoptive cell transfer therapy. Our new system represents a valuable tool in which to explore the mechanisms that contribute to T cell tolerance to cancer and to evaluate therapies aimed at overcoming this tolerance. In addition, our model provides a platform, on which more advanced mouse models of human cancer can be generated for cancer immunology.
by Ann F. Cheung.
Ph.D.
Loughhead, Scott McNabb. "Immune Surveillance by Effector and Memory CD8+ T Cells". Thesis, Harvard University, 2016. http://nrs.harvard.edu/urn-3:HUL.InstRepos:26718721.
Pełny tekst źródłaMedical Sciences
Sowinski, Stefanie. "Transmission and immune surveillance of human T cell-tropic retroviridae". Thesis, Imperial College London, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.501764.
Pełny tekst źródłaTextor, Johannes [Verfasser]. "Search and learning in the immune system : models of immune surveillance and negative selection / Johannes Textor". Lübeck : Zentrale Hochschulbibliothek Lübeck, 2012. http://d-nb.info/1024336921/34.
Pełny tekst źródłaBlaimer, Stephanie [Verfasser], i Edward K. [Akademischer Betreuer] Geissler. "Impact of innate and adaptive immune cells in tumor immune surveillance / Stephanie Blaimer ; Betreuer: Edward K. Geissler". Regensburg : Universitätsbibliothek Regensburg, 2020. http://d-nb.info/1210729202/34.
Pełny tekst źródłaStrickland, Ian. "The role of immune surveillance in inflammatory reactions in human skin". Thesis, University of Liverpool, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.307670.
Pełny tekst źródłaKsiążki na temat "Surveillance immune"
Sonnenfeld, Gerald. Cytokines and immune surveillance in humans: Fifth semi-annual progress report. [Washington, DC: National Aeronautics and Space Administration, 1993.
Znajdź pełny tekst źródłaSmith, Richard T. Immune Surveillance. Elsevier Science & Technology Books, 2012.
Znajdź pełny tekst źródłaCytokines and immune surveillance in humans. [Washington, DC: National Aeronautics and Space Administration, 1994.
Znajdź pełny tekst źródłaKishore, Uday, Roberta Bulla i Taruna Madan, red. Odyssey of Surfactant Proteins SP-A and SP-D: Innate Immune Surveillance Molecules. Frontiers Media SA, 2020. http://dx.doi.org/10.3389/978-2-88963-680-8.
Pełny tekst źródłaEpidemiological surveillance of current infections: new threats and challenges. Remedium Privolzhye, 2021. http://dx.doi.org/10.21145/978-5-6046124-2-2_2021.
Pełny tekst źródłaCate, Fred H., i James X. Dempsey, red. Bulk Collection. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190685515.001.0001.
Pełny tekst źródłaDalbeth, Nicola. Pathophysiology of gout. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199668847.003.0039.
Pełny tekst źródłaSherman, Mark E., Melissa A. Troester, Katherine A. Hoadley i William F. Anderson. Morphological and Molecular Classification of Human Cancer. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0003.
Pełny tekst źródłaStewart, Alex G., Sam Ghebrehewet i Peter MacPherson. New and emerging infectious diseases. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198745471.003.0026.
Pełny tekst źródłaCzęści książek na temat "Surveillance immune"
Mitchison, N. A. "Immune Surveillance". W Investigation and Exploitation of Antibody Combining Sites, 335. Boston, MA: Springer US, 1985. http://dx.doi.org/10.1007/978-1-4684-5006-4_40.
Pełny tekst źródłaKoga, Tetsuya. "Immune Surveillance against Dermatophyte Infection". W Fungal Immunology, 443–52. Boston, MA: Springer US, 2005. http://dx.doi.org/10.1007/0-387-25445-5_22.
Pełny tekst źródłaJung, M. Katherine. "Immune Surveillance and Tumor Evasion". W Alcohol and Cancer, 193–210. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-0040-0_10.
Pełny tekst źródłaMastrangelo, Domenico. "Immune Surveillance and Cancer Pathogenesis". W Orbital Tumors, 9–20. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-1510-1_2.
Pełny tekst źródłaRoy, Moumita. "Alternative Splicing and Immune Surveillance". W Alternative Splicing and Cancer, 125–44. Boca Raton: CRC Press, 2024. http://dx.doi.org/10.1201/9781003260394-8.
Pełny tekst źródłaHuso, David L., i Opendra Narayan. "Escape of Lentiviruses from Immune Surveillance". W Virus Variability, Epidemiology and Control, 61–73. Boston, MA: Springer US, 1990. http://dx.doi.org/10.1007/978-1-4757-9271-3_5.
Pełny tekst źródłaUenotsuchi, Takeshi, Tetsuo Matsuda, Masutaka Furue i Tetsuya Koga. "Immune Surveillance against Sporothrix schenckii Infection". W Fungal Immunology, 453–58. Boston, MA: Springer US, 2005. http://dx.doi.org/10.1007/0-387-25445-5_23.
Pełny tekst źródłaVan den Eynde, B., B. Lethé, A. Van Pel i T. Boon. "Tumor Rejection Antigens and Immune Surveillance". W Modern Trends in Human Leukemia IX, 279–85. Berlin, Heidelberg: Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-76829-3_42.
Pełny tekst źródłaChen, Peter W., i Bruce R. Ksander. "Influence of Immune Surveillance and Immune Privilege on Formation of Intraocular Tumors". W Immune Response and the Eye, 276–89. Basel: KARGER, 2007. http://dx.doi.org/10.1159/000099278.
Pełny tekst źródłaPaape, Max J., Kimberly Shafer-Weaver, Anthony V. Capuco, Kaat Van Oostveldt i Christian Burvenich. "Immune Surveillance of Mammary Tissue by Phagocytic Cells". W Biology of the Mammary Gland, 259–77. Boston, MA: Springer US, 2002. http://dx.doi.org/10.1007/0-306-46832-8_31.
Pełny tekst źródłaStreszczenia konferencji na temat "Surveillance immune"
Dudimah, Duafalia F., Roman V. Uzhachenko, Samuel T. Pellom, Asel K. Biktasova, Mikhail M. Dikov, David P. Carbone i Anil Shanker. "Abstract 3983: Resuscitating immune surveillance in cancer." W Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-3983.
Pełny tekst źródłaAgudo, Judith, Miriam Merad i Brian D. Brown. "Abstract A168: Quiescent stem cells evade immune surveillance". W Abstracts: Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 30 - October 3, 2018; New York, NY. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr18-a168.
Pełny tekst źródłaBandyopadhyay, G., H. L. Huyck, S. Bhattacharya, R. Misra, J. Lillis, J. Myers, S. Romas i in. "Respiratory Epithelial Cell Regulation of Pulmonary Immune Surveillance". W American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2130.
Pełny tekst źródłaKuttke, Mario, Emine Sahin, Julia Pisoni, Sophie Percig, Andrea Vogel, Daniel Kraemmer, Leslie Hanzl i in. "Abstract 527: Myeloid PTEN deficiency impairs tumor immune surveillance via immune checkpoint inhibition". W Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-527.
Pełny tekst źródłaRazia, D., H. Abdelrazek, H. Mohamed i A. Arjuna. "De Novo Prostate Adenocarcinoma in a Lung Transplant Recipient: Immune-surveillance or Immune-suppression?" W American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a5219.
Pełny tekst źródłaDudimah, Duafalia F., Samuel T. Pellom, Roman V. Uzhachenko, David P. Carbone, Mikhail M. Dikov i Anil Shanker. "Abstract 3642: Cancer therapy by resuscitating Notch immune surveillance". W Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-3642.
Pełny tekst źródłaZal, M. Anna, Todd Bartkowiak, Grzegorz Chodaczek, Veena Papanna, Meenakshi Shanmugasundaram i Tomasz Zal. "Abstract 4290: Visualizing immune surveillance in lung metastasis progression". W Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-4290.
Pełny tekst źródłaJohnstone, Ricky W. "Abstract IA25: Epigenetic regulation of cancer immune surveillance processes". W Abstracts: Second AACR Conference on Hematologic Malignancies: Translating Discoveries to Novel Therapies; May 6-9, 2017; Boston, MA. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1557-3265.hemmal17-ia25.
Pełny tekst źródłaVonderheide, Robert H. "Abstract SY09-01: Inflammatory networks and cancer immune surveillance." W Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-sy09-01.
Pełny tekst źródłaBardelli, Alberto. "Abstract IA18: Inactivation of DNA repair to improve immune surveillance". W Abstracts: Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 30 - October 3, 2018; New York, NY. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr18-ia18.
Pełny tekst źródłaRaporty organizacyjne na temat "Surveillance immune"
Luo, Yunping, i Ralph A. Reisfeld. Priming the Tumor Immune Microenvironment Improves Immune Surveillance of Cancer Stem Cells and Prevents Cancer Recurrence. Fort Belvoir, VA: Defense Technical Information Center, październik 2012. http://dx.doi.org/10.21236/ada574527.
Pełny tekst źródłaReisfeld, Ralph R., Debbie Liao i Yunping Luo. Priming the Tumor Immune Microenvironment Improves Immune Surveillance of Cancer Stem Cells and Prevents Cancer Recurrence. Fort Belvoir, VA: Defense Technical Information Center, październik 2011. http://dx.doi.org/10.21236/ada553886.
Pełny tekst źródłaBovbjerg, Dana H. Immune Surveillance, Cytokines and Breast Cancer Risk: Genetic and Psychological Influences in African American Women. Fort Belvoir, VA: Defense Technical Information Center, sierpień 2003. http://dx.doi.org/10.21236/ada418645.
Pełny tekst źródłaBovbjerg, Dana H. Inherited Susceptibility to Breast Cancer in Healthy Women: Mutation in Breast Cancer Genes, Immune Surveillance, and Psychological Distress. Fort Belvoir, VA: Defense Technical Information Center, październik 2001. http://dx.doi.org/10.21236/ada403466.
Pełny tekst źródłaBovbjerg, Dana H. Inherited Susceptibility to Breast Cancer in Healthy Women: Mutation in Breast Cancer Genes, Immune Surveillance, and Psychological Distress. Fort Belvoir, VA: Defense Technical Information Center, październik 2003. http://dx.doi.org/10.21236/ada427835.
Pełny tekst źródłaBovbjerg, Dana H. Inherited Susceptibility to Breast Cancer in Healthy Women: Mutation in Breast Cancer Genes, Immune Surveillance, and Psychological Distress. Fort Belvoir, VA: Defense Technical Information Center, październik 2004. http://dx.doi.org/10.21236/ada431795.
Pełny tekst źródłaBovbjerg, Dana H. Inherited Susceptibility to Breast Cancer in Healthy Women: Mutation in Breast Cancer Genes, Immune Surveillance, and Psychological Distress. Fort Belvoir, VA: Defense Technical Information Center, październik 2002. http://dx.doi.org/10.21236/ada410581.
Pełny tekst źródłaGupte, Jaideep, Sarath MG Babu, Debjani Ghosh, Eric Kasper i Priyanka Mehra. Smart Cities and COVID-19: Implications for Data Ecosystems from Lessons Learned in India. Institute of Development Studies (IDS), marzec 2021. http://dx.doi.org/10.19088/sshap.2021.034.
Pełny tekst źródłaGupte, Jaideep, Sarath MG Babu, Debjani Ghosh, Eric Kasper, Priyanka Mehra i Asif Raza. Smart Cities and COVID-19: Implications for Data Ecosystems from Lessons Learned in India. Institute of Development Studies, marzec 2022. http://dx.doi.org/10.19088/sshap.2022.004.
Pełny tekst źródłaGupte, Jaideep, Sarath MG Babu, Debjani Ghosh, Eric Kasper, Priyanka Mehra i Asif Raza. Smart Cities and COVID-19: Implications for Data Ecosystems from Lessons Learned in India. SSHAP, marzec 2021. http://dx.doi.org/10.19088/sshap.2021.012.
Pełny tekst źródła